Breadcrumb

RI-MUHC team identifies new gene associated with risk of cardiovascular diseases

New study analyses millions of genetic variants in almost 300,000 individuals

New services for cancer patients at the RI-MUHC Centre for Innovative Medicine

The Centre for Innovative Medicine and Cedars Cancer Centre jointly offer additional space for infusion treatments

What do we know about sleep apnea, pregnancy and gestational diabetes?

RI-MUHC researchers find link that may lead to better health for mother and baby

Paving the way for COVID-19 research

RI-MUHC and McGill Containment level 3 Labs receive $1M in funding to accelerate research with live SARS Cov-2

Stem cells are the marrow of the TB pandemic, which still kills one person every 22 seconds

A new study finds that not only can stem cells be targeted for protective vaccination, but they can also ...

Recovering from sleep deprivation: What is the role of astrocytes?

A new RI-MUHC study uses sleep-deprived fruit flies to study regulation of rebound sleep

Understanding the psychological trauma related to facial transplantation

Dr. Mirko Gilardino is co-author of study that examines issues around patients’ consent

Gene therapy to restore sight coming to the Montreal Children's Hospital and to Quebec

Dozens of young patients will be among the first in Canada to benefit from this treatment, which improves vision...

Supporting those grieving requires “literacy,” researcher Mary Ellen Macdonald suggests

Grief amidst the pandemic is an increasing reality in communities worldwide

Spike in peanut and nut anaphylaxis in children at Halloween and Easter

New study suggests education and awareness are needed to help reduce risk of anaphylaxis at specific times of the year

Sleep apnea treatment reduces heart problems in patients with prediabetes, a new study finds

People with prediabetes and obstructive sleep apnea could reduce their daytime resting heart rate and risk of cardiovascular disease by using a CPAP machine at night

Containment Level 3 facilities advance COVID-19 research at the RI-MUHC and McGill

Infrastructure to study COVID-19 in a secure environment is creating new possibilities for collaboration and discovery

From silent infection to rapid death: Why are some people more vulnerable to COVID-19?

Scientists discover genetic and immunological causes of 15 percent of life-threatening COVID-19 cases

15,000 COVID-19 tests produced by McGill University and the RI-MUHC: a step toward Canadian self-sufficiency

In July 2020, the McGill University Health Centre’s (MUHC's) Department of Clinical...

Protecting lung cancer patients from COVID-19 – and learning from the experience

A study led by Dr. Nathaniel Bourganim tracked changes in treatment plans

New study of therapy options in metastatic melanoma

RI-MUHC researchers lead “real-world” analysis of treatment patterns with checkpoint inhibitors

Nip it in the bud: New study will attack SARS-Cov2 where it multiplies

RI-MUHC researchers initiate a clinical trial of ciclesonide to possibly prevent mild cases of COVID-19 from worsening

Serious Flaws in Studies Linking COVID-19 and Air Pollution

Studies have yet to prove this link, say Carleton and McGill University epidemiologists